image
Madrigal Pharmaceuticals, Inc. MDGL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 285.73
1.06 %
$ 6.34 B
Market Cap
-16.01
P/E
Price Target Average
38.88%
Revenue Forecast Estimate
114.39%
EBIT Estimate
60.20%
Net Income Estimate
52.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Madrigal Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for MDGL of $397 , with forecasts ranging from a low of $336 to a high of $420 .
MDGL Lowest Price Target Wall Street Target
336 USD 17.59%
MDGL Average Price Target Wall Street Target
397 USD 38.88%
MDGL Highest Price Target Wall Street Target
420 USD 46.99%
Price
Max Price Target
Min Price Target
Average Price Target
450450400400350350300300250250200200Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart MDGL

image
$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201920192020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MDGL

image
$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)201920192020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MDGL

image
$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)201920192020202020232023202420242025202520262026202720272028202820292029